This is a news story, published by BBC, that relates primarily to Ozempic news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from BBC, you can click here:
more news from BBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
cardiovascular medicine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cardiovascular health news, fewer major adverse cardiovascular events news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
OzempicBBC
•
74% Informative
Semaglutide, better known as Ozempic , could be used to treat a wide range of illnesses linked to heart failure, arthritis, Alzheimer's and cancer.
The drug could also slow down the ageing process, Yale School of Medicine Prof Harlan Krumholz said following the publication of several new studies.
The studies tracked more than 17,600 people, aged 45 or older , as they were given either 2.4 mg of semaglotide or a placebo for three years .
VR Score
62
Informative language
55
Neutral language
58
Article tone
formal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links